Find the right fit for you - faster
Get tailored insights about working at NeurogesX in one quick step.
NeurogesX Snapshot
NeurogesX is paving the way for treating neuropathic pain, or chronic pain caused by damaged nerves. The company's lead candidate is Qutenza (formerly known as NGX-4010), a skin patch that uses a synthetic version of capsaicin (an ingredient in hot peppers) to lessen nerve pain. NeruogesX has been developing the drug in the US and Europe for a number of pain indications, including post-herpetic neuralgia (caused by shingles), diabetic neuropathy, and neuropathic pain associated with HIV. However, the drug is furthest advanced in the US as a treatment for post-herpetic neuralgia. Other product candidates in the NeurogesX pipeline include a liquid formulation of synthetic capsaicin and an opioid pain reliever.
